Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1999
05/12/1999CN1216545A Farnesyl transferase inhibitors
05/12/1999CN1216544A Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use
05/12/1999CN1216541A N-3 substituted pyrimidin-4-ones with all antagonistic activity
05/12/1999CN1216540A 2,1,3-benzothia (oxa) diazole derivatives having an endothelin receptor antagonistic effect
05/12/1999CN1216539A Antivirally active heterocyclic azahexane derivatives
05/12/1999CN1216537A Compounds with growth hormone releasing properties
05/12/1999CN1216531A Indole derivatives useful as endothelin receptor antagonists
05/12/1999CN1216527A Process for scavenging thiols
05/12/1999CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
05/12/1999CN1216470A DHEA combination therapy
05/12/1999CN1216469A Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines
05/12/1999CN1216468A Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
05/12/1999CN1216467A Immediate release PH-independent solid dosage form of cisapride
05/12/1999CN1216460A Oxa diacids and related compounds for treating skin conditions
05/12/1999CN1216253A Cancer curing medicine liquid
05/12/1999CN1216246A Antimicrobial composition
05/12/1999CN1043349C New sulfuric acid esters of sugar alcohols and producing process and its application
05/12/1999CN1043348C Asymmetrically substituted xanthines its producting process and its application as pharmaceutical composition
05/12/1999CN1043347C 2-heteroaryl-5,11-dihydro-6H-dipyrido [3,2-b: 2',3'-3]-3] [1,4] diazepines and their use in the prevention or treatment of HIV infection
05/12/1999CN1043344C New heterocyclic compounds, preparing method, pharmaceutical composition and use
05/12/1999CN1043303C Ferric selenium injection for animal
05/12/1999CN1043302C Medicine with function of relieving cough and reducing sputum
05/11/1999US5902831 Administering reduced nicotinamide-adenine dinucleotide phosphate oxidase inhibitor to treat condition resulting from endothelial hyperpermeability
05/11/1999US5902830 Lowering plasma cholesterol levels
05/11/1999US5902829 Administering prior to surgery a modulating mixture of l-arginine or a precursor thereof and a carrier; prevention of hypoperfusion-reperfsion injury and amelioration of hypoperfusion; substrate for nitic oxide synthetase;
05/11/1999US5902827 Administering compounds having fewer side effects
05/11/1999US5902826 Water soluble diamine-platinum (iv) complex; side effect reduction, water soluble, treatment of malignant tumors
05/11/1999US5902824 Phenyldihydrobenzofuranes
05/11/1999US5902823 Method for treating addiction using forskolin or extracts containing forskolin
05/11/1999US5902822 Novel antitumor derivatives for use as antitumor agents
05/11/1999US5902821 Use of carbazole compounds for the treatment of congestive heart failure
05/11/1999US5902819 Triazole derivatives
05/11/1999US5902817 2-sulfinyl or sulfonylpentandioic acids; inhibitors of n-acetylated alpha-linked acidic dipeptidase; glutamate abnormalities; prostates; antiepileptic and -ischemic agents; strokes; analgesics; nervous sytem injuries;
05/11/1999US5902816 Method for treatment of heavy metal poisoning
05/11/1999US5902815 Reducing neurological side effects of n-methyl-d-aspartate antagonists
05/11/1999US5902814 Treating psychotic disorder, intellectual disorders and anxiety, such as attention deficit hyperactivity disorder and schizophrenia
05/11/1999US5902813 Modulators of the benzodiaxepine receptor ot the gamma-butyric acid(a) receptor complex; anxiolytic, antiepileptic and -convulsant agents; sleep and memory disorders
05/11/1999US5902812 Inhibitors of plasminogen activator inhibitor
05/11/1999US5902811 Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
05/11/1999US5902810 Pteridine derivatives as no synthase inhibitors
05/11/1999US5902809 Arglabin compounds and therapeutic uses thereof
05/11/1999US5902807 Administering alpha-2-adrenoceptor antagonist selective for alpha-2c-adrenoceptor subtype
05/11/1999US5902805 Treating of skin aging by desquamation of skin cells, comprises administering to the patient an effective amount of hydroxy-3-methylglutaryl/3-/ coenzyme reductase inhibitor selected from mevastatine, lovastatine, fluvastatine etc.
05/11/1999US5902804 Administering a n-phosphonoglycine derivatives as an anticarcinogenic and antiviricide in human
05/11/1999US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
05/11/1999US5902802 Cationic amphiphiles
05/11/1999US5902800 Dextran formulations and method for treatment of inflammatory joint disorders
05/11/1999US5902799 Methods of modulating tissue growth and regeneration
05/11/1999US5902798 Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate
05/11/1999US5902796 Bioactive factors of aloe vera plants
05/11/1999US5902795 Oligosaccharides reactive with hyaluronan-binding protein and their methods of use
05/11/1999US5902794 Camp derivatives, one is selective for site 1 of a type ii camp dependent protein kinase and the other is selective for site 2 of type i or ii camp dependent protein kinase, having a synergistic inhibitory effect on cancer cell growth
05/11/1999US5902793 Method for proliferating Vγ2Vδ2 T cells
05/11/1999US5902792 Method of inducing apoptosis in cancer cells
05/11/1999US5902791 Metalloproteinase inhibitors
05/11/1999US5902789 Intranasally administering composition consisting of insulin, polysorbate-80, nonoxynol-9; reduced nasal irritation
05/11/1999US5902632 Method of preparation of controlled release nifedipine formulations
05/11/1999US5902610 Formulations and methods of use of 2,2'-dithio-bis-ethane sulfonate
05/11/1999US5902609 Composition for the control of wound scar production
05/11/1999US5902604 Submicron liposome suspensions obtained from preliposome lyophilizates
05/11/1999US5902602 Estradiol-TTS having water-binding additives
05/11/1999US5902601 Volatile active substance containing plaster that may be produced without solvents
05/11/1999US5902598 Sustained release drug delivery devices
05/11/1999US5902594 Cyanoacrylate compositions comprising an antimicrobial agent
05/11/1999US5902588 Water soluble nonantigenic polymer with a secondary or tertiary amine, spacer moiety and covalent linkage to a nucleophile consisting of proteins and chemotherapeutic agents; improved bioactivity, pi and ph optimum
05/11/1999US5902587 Subjecting fresh camomile to steam or aqueous distillation to produce camomile oil having high content of natural spiroethers
05/11/1999US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists
05/11/1999US5902583 Genetic induction of receptors for targeted radiotherapy
05/11/1999US5902567 Administering to lung by inhalation physiologically acceptable salt to hydrate secretions, concurrently administering uridine triphosphate or derivative to stimulate secretion, collecting expectorated mucus sample
05/11/1999CA2160874C Nasal aromatic releasing compositions
05/11/1999CA2129652C Aids prophylactic lubricatng composition and devices for its use
05/11/1999CA2129541C Method of promoting nitrogen retention in humans
05/11/1999CA2114014C Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
05/11/1999CA2079485C Chelator compositions comprising oxime compounds
05/11/1999CA2001889C Zinc cysteate, its preparation and uses in pharmacy and cosmetology
05/07/1999CA2220621A1 Transdermal delivery system
05/06/1999WO1999022243A1 148 human secreted proteins
05/06/1999WO1999022240A1 Pharmaceutical uses of cdk-2 regulators
05/06/1999WO1999022000A1 Inhibitor protein of the wnt signal pathway
05/06/1999WO1999021871A1 2-halo-6-o-substituted ketolide derivatives
05/06/1999WO1999021870A1 Erythromycin a 11, 12-carbamate derivatives
05/06/1999WO1999021869A1 Erythromycin a, 11,12-carbamate derivatives
05/06/1999WO1999021864A1 6,11-bridged erythromycin derivatives
05/06/1999WO1999021862A1 Sarcodictyin and eleutherobin useful for stabilising microtubules
05/06/1999WO1999021860A1 Phenanthroline derivatives
05/06/1999WO1999021858A1 Synthesis of swainsonine salts
05/06/1999WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
05/06/1999WO1999021856A1 Aminomethyl-benzo[a]quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases
05/06/1999WO1999021855A1 Pleuromutilin derivatives as antimicrobials
05/06/1999WO1999021854A1 Bis-quaternary ammonium derivatives as neuromuscular relaxants
05/06/1999WO1999021849A1 Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient
05/06/1999WO1999021846A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
05/06/1999WO1999021845A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
05/06/1999WO1999021843A1 4, 5-diaryloxazole compounds
05/06/1999WO1999021836A1 Substituted isoquinoline derivatives and their use as anticonvulsants
05/06/1999WO1999021835A1 QUINOLINE DERIVATIVES AS H+-ATPase INHIBITORS AND AS BONE RESORPTION INHIBITORS
05/06/1999WO1999021834A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
05/06/1999WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors
05/06/1999WO1999021830A1 Process for stereoselective synthesis of prostacyclin derivatives
05/06/1999WO1999021829A1 Dofetilide polymorphs
1 ... 6502 6503 6504 6505 6506 6507 6508 6509 6510 6511 6512 6513 6514 6515 6516 6517 6518 6519 6520 6521 6522 ... 7860